Bericht
The World Health Organization reforms in the time of COVID-19
During its 70-year history, the World Health Organization (WHO) has undergone various reforms led by several Directors-General, including Halfdan Mahler at the Almaty Conference on primary health care in 1978, Gro Harlem Brundtland with her “reach out to the private sector” in 1998, and Margaret Chan with her unfinished debate on the role of “non-state actors” in 2012. The organization’s fragility is once again being highlighted, as the COVID-19 pandemic has revealed that WHO does not have the legal instruments and mechanisms necessary to enforce its standards and guidelines, and that its funding is not sustainable and adequate to respond to the challenge. This paper seeks to identify the main problems faced by WHO and the necessary measures that a reform of the organization would have to take.
- Language
-
Englisch
- Bibliographic citation
-
Series: Research Paper ; No. 121
- Classification
-
Sozialwissenschaften, Soziologie, Anthropologie
- Subject
-
Article 19 WHO Constitution
Coronavirus
COVID-19
France
Germany
Global Health
Health
International Health Regulations (IHR)
Non-Paper on Strengthening WHO
Pandemic
Public Health
WHO
WHO Executive Board (EB)
WHO Reform
World Health Assembly (WHA)
World Health Organization
- Event
-
Geistige Schöpfung
- (who)
-
Velásquez, Germán
- Event
-
Veröffentlichung
- (who)
-
South Centre
- (where)
-
Geneva
- (when)
-
2020
- Handle
- Last update
- 10.03.2025, 11:45 AM CET
Data provider
This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
Object type
- Bericht
Associated
- Velásquez, Germán
- South Centre
Time of origin
- 2020
Other Objects (12)
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Analysis of the Doha negotiations and the functioning of the World Trade Organization
Access to medicines and intellectual property: The contribution of the World Health Organization
Leading and coordinating global health: Strengthening the World Health Organization
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Can negotiations at the World Health Organization lead to a just framework for the prevention, preparedness and response to pandemics as global public goods?
The staggering rise of the South?
Interpreting the flexibilities under the TRIPS agreement
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU: The need to rebalance
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
Is the right to use trademarks mandated by the TRIPS Agreement?
The MDGs beyond 2015
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Analysis of the Doha negotiations and the functioning of the World Trade Organization
Access to medicines and intellectual property: The contribution of the World Health Organization
Leading and coordinating global health: Strengthening the World Health Organization
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Can negotiations at the World Health Organization lead to a just framework for the prevention, preparedness and response to pandemics as global public goods?
The staggering rise of the South?
Interpreting the flexibilities under the TRIPS agreement
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU: The need to rebalance
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
Is the right to use trademarks mandated by the TRIPS Agreement?
The MDGs beyond 2015
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Analysis of the Doha negotiations and the functioning of the World Trade Organization
Access to medicines and intellectual property: The contribution of the World Health Organization
Leading and coordinating global health: Strengthening the World Health Organization
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Can negotiations at the World Health Organization lead to a just framework for the prevention, preparedness and response to pandemics as global public goods?
The staggering rise of the South?
Interpreting the flexibilities under the TRIPS agreement
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU: The need to rebalance
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
Is the right to use trademarks mandated by the TRIPS Agreement?